Patents by Inventor Urska Lesnik

Urska Lesnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9630911
    Abstract: The invention relates to tetracycline products produced by genetically engineered cells, and to therapeutic methods using such tetracyclines. The present invention is based on the cloning and heterologous expression of genes encoding the chelocardin biosynthetic pathway.
    Type: Grant
    Filed: January 28, 2013
    Date of Patent: April 25, 2017
    Assignee: Univerza v Ljubljani
    Inventors: Hrvoje Petkovic, Peter Raspor, Urska Lesnik
  • Patent number: 8361777
    Abstract: The invention relates to genetically engineered cells, and to proteins and genes useful in the production of tetracycline compounds, to methods of producing tetracycline compounds, and to tetracyclines thereby produced. The present invention is based on the cloning and heterologous expression of genes encoding the chelocardin biosynthetic pathway.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: January 29, 2013
    Assignee: Univerza v Ljubljani
    Inventors: Hrvoje Petkovic, Peter Raspor, Urska Lesnik
  • Publication number: 20100035847
    Abstract: The invention relates to genetically engineered cells, and to proteins and genes useful in the production of tetracycline compounds, to methods of producing tetracycline compounds, and to tetracyclines thereby produced. The present invention is based on the cloning and heterologous expression of genes encoding the chelocardin biosynthetic pathway.
    Type: Application
    Filed: August 6, 2009
    Publication date: February 11, 2010
    Inventors: Hrvoje Petkovic, Peter Raspor, Urska Lesnik